Balchem makes specialty ingredients and performance chemicals for human nutrition, animal nutrition and industrial markets. It is known for microencapsulation and nutrient-delivery technologies—such as choline and other functional ingredients used in dietary supplements, food fortification and livestock feed. That application science focus sets it apart from bulk commodity chemical makers. Customers include food and supplement manufacturers, animal-feed companies and industrial users of specialty formulations.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 250.5 | — | 37 | 11.5% |
| Q2 2025 | 255.5 | — | 38.3 | 8.3% |
| Q3 2025 | 267.6 | — | 40.3 | 9.9% |
| Q4 2025 | 263.6 | — | 39.2 | 6.8% |
| Q1 2026 | 270.7 | 8.1% | 40.3 | 8.7% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Frontdoor, Inc. (FTDR), Novanta Inc. (NOVT), CRISPR Therapeutics AG (CRSP), Cirrus Logic, Inc. (CRUS), MakeMyTrip Limited (MMYT), Phillips Edison & Company, Inc. (PECO)